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The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate
receptors (AMPARs) are major excitatory receptors that mediate fast neurotransmission
in the mammalian brain. The surface expression of functional AMPARs is crucial for
synaptic transmission and plasticity. AMPAR auxiliary subunits control the biosynthesis,
membrane trafficking, and synaptic targeting of AMPARs. Our previous report showed
that α/β-hydrolase domain-containing 6 (ABHD6), an auxiliary subunit for AMPARs,
suppresses the membrane delivery and function of GluA1-containing receptors in both
heterologous cells and neurons. However, it remained unclear whether ABHD6 affects
the membrane trafficking of glutamate receptor subunits, GluA2 and GluA3. Here, we
examine the effects of ABHD6 overexpression in HEK293T cells expressing GluA1,
GluA2, GluA3, and stargazin, either alone or in combination. The results show that
ABHD6 suppresses the glutamate-induced currents and the membrane expression of
AMPARs when expressing GluA2 or GluA3 in the HEK293T cells. We generated a series
of GluA2 and GluA3 C-terminal deletion constructs and confirm that the C-terminus
of GluAs is required for ABHD6’s inhibitory effects on glutamate-induced currents and
surface expression of GluAs. Meanwhile, our pull-down experiments reveal that ABHD6
binds to GluA1–3, and deletion of the C-terminal domain of GluAs abolishes this binding.
These findings demonstrate that ABHD6 inhibits the AMPAR-mediated currents and its
surface expression, independent of the type of AMPAR subunits, and this inhibitor’s
effects are mediated through the binding with the GluAs C-terminal regions.
Keywords: AMPA receptor, ABHD6, receptor trafficking, glutamates, protein–protein interactions
INTRODUCTION
In the mammalian brain, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type
glutamate receptors (AMPARs) are major ionotropic receptors that mediate the majority of
fast excitatory synaptic transmissions. The binding of the glutamate released from presynaptic
terminals with postsynaptic AMPARs determines the efficiency and plasticity of synaptic
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transmission between pairs of neurons. The numbers and
biophysical properties of AMPARs remain dynamically
modulated during periods of rest and plasticity, and deficits
in these processes are strongly linked to psychiatric and
neurodegenerative diseases, including Huntington’s disease and
Alzheimer’s disease (Keinänen et al., 1990; Jackson and Nicoll,
2011; Huganir and Nicoll, 2013; Henley and Wilkinson, 2016).
AMPARs are tetramers assembled from four AMPAR
subunits: GluA1–4 (Hollmann and Heinemann, 1994). The
subunit composition determines the biophysical and molecular
properties of AMPARs. The C-terminus of AMPARs interacts
with proteins, such as PICK1, NSF, GRIP1, SAP97, and NSF, to
traffic the receptors to the plasma membrane and the synapse
in both constitute and activity-dependent manners (see reviews
Ziff, 2007; Anggono and Huganir, 2012; Cheng et al., 2012; Yang
et al., 2014). For example, PICK1 causes a selective decrease
in the surface expression levels of GluA2, while the surface
expression levels of GluA1 remain unchanged, suggesting that
PICK1 regulates the subunit composition and synaptic targeting
of surface AMPARs (Terashima et al., 2004; Cao et al., 2007;
Xu et al., 2016). GluA2 confers the calcium permeability to the
AMPARs; while GluA2-containing receptors are not calcium
permeable, GluA1-containing receptors are calcium permeable.
All AMPAR subunits are subject to alternative splicing to
generate either “flop” or “flip” versions of the receptors, while
only GluA2 undergoes Q/R RNA editing (Burnashev et al., 1992).
The gating, pharmacology, trafficking, and localization of
AMPARs are regulated by not only the subunit composition
of GluA subunits, but also the AMPARs auxiliary subunits
proteins (Bredt and Nicholl, 2003; Li et al., 2016). Stargazin was
identified as the first member in the family of transmembrane
AMPAR regulatory proteins (TARPs; Letts et al., 1998; Chen
et al., 1999, 2000; Hashimoto et al., 1999), and ever since, more
and more AMPAR-associated proteins are identified, mainly
using proteomics approaches. Native AMPARs associate with
a variety of regulatory proteins, including TARPs, cornichon-2
and -3, cystine-knot AMPAR modulating protein of 44 kDa
(CKAMP44), germ cell-specific gene 1-like protein (GSG1L),
α/β-hydrolase domain-containing 6 (ABHD6), porcupine
(PORCN), etc. (Vandenberghe et al., 2005; Tomita et al.,
2006; Milstein and Nicoll, 2008; Coombs et al., 2012; Schwenk
et al., 2012; Gu et al., 2016b; Wei et al., 2016). The functional
analysis of these proteins reveals the AMPARs’ important
and distinct roles in both neurons and heterologous cells. For
example, type I TARPs (stargazin, γ-3, γ-4, γ-8) are necessary
and sufficient for the delivery of AMPARs to the plasma
membrane in cerebellum granule cells. Furthermore, type I
TARPs also modulate the properties of the AMPAR channels
by reducing desensitization and slowing the deactivation of
the AMPARs (Priel et al., 2005; Tomita et al., 2006). GSG1L
and ABHD6 suppress AMPAR-mediated synaptic transmission
and modulate its kinetics in hippocampal neurons (Gu et al.,
2016a; Wei et al., 2016). Cornichon-2 and -3 conditional
knock-out mice showed selective reduction of surface GluA1-
containing subunits, and impaired strength and kinetics of
AMPAR-mediated synaptic transmission. This is likely due
to the effect of TARPγ-8, which can mediate the functional
interaction between CNIHs and AMPARs, thus promoting the
association of CNIHs with the GluA1 subunit and preventing
the association of CNIHs with other subunits (Herring et al.,
2013).
We previously showed that ABHD6, a monoacylglycerol
lipase, can bind to the C-terminus of GluA1. Overexpression
of ABHD6 can reduce AMPAR-mediated excitatory
neurotransmission in neurons and glutamate-induced currents
in HEK293T cells in a 2-arachidonoylglycerol independent
manner. Further studies via immunostaining demonstrated that
these decreases might have been due to the decreased surface
expression levels of GluA1, rather than the overall expression
levels (Wei et al., 2016). Thus, ABHD6 seems to functionally
interact with GluA1 in both heterologous cells and cultured
hippocampal neurons. However, whether the inhibitory effect of
ABHD6 on AMPAR function depends on the type of AMPAR
subunit remains uncertain. In the present study, we investigated
the subunit specificity of ABHD6’s inhibition on AMPARs in
transfected HEK293T cells.
MATERIALS AND METHODS
Construction of Expression Vectors
Rat GluA1, GluA2, and GluA3 subunit cDNAs containing
internal ribosome entry site linked green fluorescent protein
(IRES-GFP) were used in the present study and have been
described previously (Shi et al., 2009). ABHD6-2A-GFP was
cloned into a pFUGW expression vector using polymerase chain
reaction (PCR) methods (Wei et al., 2016). GluA1, GluA2,
and GluA3 deletion constructs were generated by PCR. GluA1-
deletion 14 (A1D14) ended in SKRMK; GluA2-deletion 1
(A2D1) ended in EGYNV; GluA2-deletion 2 (A2D2) ended in
QNSQN; GluA2-deletion 3 (A2D3) ended in SQNSQ; GluA2-
deletion 4 (A2D4) ended in SSQNS; GluA2-deletion 5 (A2D5)
ended in SSSQN; GluA2-deletion 6 (A2D6) ended in PSSSQ;
GluA2-deletion 7 (A2D7) ended in NPSSS; GluA2-deletion 8
(A2D8) ended in KNPQN; GluA2-deletion 9 (A2D9) ended
in RMKVA; GluA2-deletion 10 (A2D10) ended in KRMKV;
GluA2-deletion 11 (A2D11) ended in AKRMK; GluA2-deletion
12 (A2D12) ended in EAKRM; GluA3-deletion 1 (A3D1)
ended in NTQNY; GluA3-deletion 2 (A3D2) ended in KPAPA;
GluA3-deletion 3 (A3D3) ended in FKPAP; GluA3-deletion 4
(A3D4) ended in NFKPA; GluA3-deletion 5 (A3D5) ended
in KNTQN; GluA3-deletion 6 (A3D6) ended in RMKLT;
GluA3-deletion 7 (A3D7) ended in KRMKL; and GluA3-
deletion 8 (A3D8) ended in SKRMK. All the C-terminal
deletion constructs were tagged with an human influenza
hemagglutinin (HA) tag with a linker of GQG (Figure 3A).
GluA11ATD lacked sequence from ANFPN to DDKFV,
GluA21ATD lacked sequence from VSSNS to VDKMV, and
GluA31ATD lacked sequence from GFPNT to YERFV. All
the N-terminal deletion constructs were tagged with a Flag
tag (Figure 4A). Myc-ABHD6 was cloned into a pCAG vector
using PCR methods. The constructs were verified with Sanger
sequencing.
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FIGURE 1 | Overexpression of ABHD6 decreased GluA2- or
GluA3-mediated currents in HEK293T cells co-transfected with
stargazin. All data are from HEK293T cells transfected with either an empty
vector (control) or a vector encoding ABHD6-2A-GFP in electrophysiological
experiments (A–C). (A) Representative traces (left) and summary graphs of
the peak amplitudes and plateaus (right) of 10 mM glutamate-induced
currents in HEK293T cells transfected with combinations of GluA2 and
stargazin (control: n = 30/3; ABHD6: n = 30/3; peak: p < 0.0001; plateau:
p < 0.0001). (B) Representative traces (left) and summary graphs of the peak
(Continued)
FIGURE 1 | Continued
amplitudes and plateaus (right) of 10 mM glutamate-induced currents in
HEK293T cells transfected with combinations of GluA3 and stargazin (control:
n = 27/3; ABHD6: n = 27/3; peak: p < 0.01; plateau: p < 0.01). (C)
Representative traces (left) and summary graphs of the peak amplitudes
and plateaus (right) of 10 mM glutamate-induced currents in HEK293T
cells transfected with combinations of GluA2, GluA3, and stargazin (control:
n = 24/3; ABHD6: n = 24/3; peak: p < 0.001; plateau: p < 0.01). All summary
graphs show means ± SEMs; statistical comparisons by Student’s t-test
yielded: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
HEK293T Cell Culture and Transfection
HEK293T cells (KCB Cat# KCB 200744YJ, RRID:CVCL_0063)
were used for expressing GluAs, stargazin, control, and ABHD6.
The HEK293T cells were cultured with 5% CO2 in a 37◦C
incubator (Jiang et al., 2015). The cDNA transfection was
performed in 3.5-cm dishes or six-well plates. The total cDNA
used for transfection per 3.5-cm dish or per well in six-well
plates was 4 µg. When the expression was performed, a 2:3
ratio of GluA to stargazin cDNA was used (we increased the
GluA3 to stargazin ratio to 4:1 to get detectable currents). When
GluA1 and GluA2 were coexpressed, the ratio of GluA1 to GluA2
was 3:2 (Shi et al., 2009). Transfection was terminated after
3–5 h. All of the HEK293T cell transfections were performed
using polyethylenimine (Polysciences, USA). The HEK293T cells
were dissociated with 0.05% trypsin and plated on poly-D-lysine-
pretreated coverslips after counting the cells with an automated
cell counter (µScope CellCounter Basic, Zhoushan Chengchuang
Electronic Tech. Co., China). Electrophysiological recording was
performed 24–48 h after transfection.
Electrophysiological Recordings
Electrophysiological recordings were performed as previously
reported (Zhang et al., 2009, 2010). Whole-cell voltage
clamp recordings were performed for HEK293T cells with
a MultiClamp 700A amplifier (Molecular Devices). Series
resistance was compensated to 60–70%, and recordings with
series resistances of >20 M were rejected. The data were
analyzed using Clampfit 9.02 (pClamp, RRID:SCR_011323),
Igor 4.0 (WaveMetrics), and Prism 5 (GraphPad Prism,
RRID:SCR_002798). Data were presented as mean ± SEM.
Differences in means were tested with Student’s t-test and were
accepted as significant if p < 0.05. Coverslips with transfected
HEK293T cells were maintained during the recordings in an
external solution containing (in mM) NaCl 144, KCl 10, CaCl2
2, MgCl2 1, HEPES 10, and D-glucose 10, with the pH adjusted
to 7.4, mOsm/kg 315. Using 3–5 M borosilicate glass pipettes
(World Precision Instruments), whole-cell patches were excised
from positively transfected cells identified by epifluorescence
microscopy. The internal solution contained (in mM) KCl 145,
NaCl 5, EGTA 5, MgATP 4, Na2GTP 0.3, and HEPES 10, with the
pH adjusted to 7.2, Osm 305. The glutamate-induced currents
were recorded by the local puffing of bath solution containing
potassium glutamate (10 mM), and the cells were background
perfused with bath solution at the speed of 3 mL/min.
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FIGURE 2 | Overexpression of ABHD6 decreased GluA2- or GluA3-mediated currents in transfected HEK293T cells without stargazin.
(A) Representative traces (left) and summary graphs of the peak amplitudes and plateaus (right) of 10 mM glutamate-induced currents in HEK293T cells transfected
with combinations of GluA1 and GluA2 (control: n = 24/3; ABHD6: n = 24/3; peak: p < 0.001; plateau: p < 0.05). (B) Representative traces (left) and summary
graphs of the peak amplitudes and plateaus (right) of 10 mM glutamate-induced currents in HEK293T cells transfected with combinations of GluA1 and GluA3
(control: n = 23/3; ABHD6: n = 23/3; peak: p < 0.001; plateau: p < 0.001). (C) Representative traces (left) and summary graphs of the peak amplitudes and
plateaus (right) of 10 mM glutamate-induced currents in HEK293T cells transfected with combinations of GluA2 and GluA3 (control: n = 24/3; ABHD6: n = 23/3;
peak: p < 0.01; plateau: p < 0.01). (D) Representative traces (left) and summary graphs of the peak amplitudes and plateaus (right) of 10 mM glutamate-induced
currents in HEK293T cells transfected with GluA2 (control: n = 18/3; ABHD6: n = 18/3; peak: p > 0.05; plateau: p > 0.05). (E) Representative traces (left) and
summary graphs of the peak amplitudes and plateaus (right) of 10 mM glutamate-induced currents in HEK293T cells transfected with GluA3 (control: n = 18/3;
ABHD6: n = 18/3; peak: p > 0.05; plateau: p > 0.05). (F) Representative traces (left) and summary graphs of the peak amplitudes and plateaus (right) of 10 mM
glutamate-induced currents in HEK293T cells transfected with stargazin (control: n = 18/3; ABHD6: n = 18/3; peak: p > 0.05; plateau: p > 0.05). All summary
graphs show means ± SEMs; statistical comparisons by Student’s t-test yielded: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Immunostaining Analyses
Immunofluorescence analyses were performed as previously
described. Experiments were performed under non-
permeabilized conditions to label the surface of the GluAs
receptors. The coverslips with transfected HEK293T cells were
washed once with phosphate-buffered saline (PBS). The PBS
solution contained (g/L) NaH2PO4·H2O 3.1, Na2HPO4 10.9
and NaCl 9, with the pH adjusted to 7.4, Osm 310, fixed with
4% formaldehyde in PBS for 12 min at room temperature
(RT), washed three times with PBS, and then blocked with PBS
containing 3% goat serum and 5% milk for 30 min at RT. The
cells were then incubated for 2 h at RT with the primary antibody
(Millipore Cat# AB1504 RRID:AB_2113602; HA 1:1000 Abmart)
diluted in a blocking solution. Either a donkey anti-rabbit Alexa
Fluor 546-conjugated secondary antibody (Life Technologies)
or a goat anti-mouse Alexa Fluor 633-conjugated secondary
antibody (Life Technologies) was used at 1:500 according to the
source of primary antibody. The cells were incubated for 1 h at
RT with the secondary antibody and washed three to five times
with PBS. To label the total GluAs, 0.2% triton was used 5 min
after fixation. Fluoromount-G (Southern Biotech) was used to
mount the cells on microscope slides. Images were acquired
with a laser scanning confocal microscope (Olympus), and were
further analyzed in a blinded fashion using the National Institutes
of Health (NIH) ImageJ program (ImageJ, RRID:SCR_003070).
Affinity Chromatography Experiments
and Western Blotting
To examine the binding region of GluAs with ABHD6 in
HEK293T cells, 7.5 µg full-length GluAs or GluAs deletion
plasmids, together with 2.5 µg ABHD6, were transfected in a 60-
mm dish. A pCAG empty vector was used as control. The cells
were harvested 48 h after transfection. The HEK293T cells were
washed with PBS once, kept at −80◦C overnight, and thawed
at 37◦C for 1 min. Then, the cells were collected with PBS and
centrifuged at 17,000×g for 1 min at 4◦C to obtain the cell pellets.
200 µl of buffer A (150 mM NaCl, 20 mM HEPES, 2 mM CaCl2,
2 mM MgCl2, 0.1 mM EDTA, 1% Triton, and protease inhibitors)
was added to the cell pellets. Proteins were solubilized by gentle
rocking at 4◦C for 2 h. Next, the insoluble fractions were removed
by centrifugation at 17,000×g for 30 min. A total of 150 µl of
supernatant was used for an affinity chromatography assay, and
16 µl were used as inputs. 3 µl anti-myc antibodies (M20002,
Abmart) and 24 µl of protein G beads were added to samples
and rotated overnight at 4◦C. Then, the beads were washed five
times with wash buffer (150 mM NaCl, 20 mM HEPES, 2 mM
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FIGURE 3 | The C-terminus of GluAs mediated the inhibitory effect of ABHD6. (A) The amino acid sequences of different GluA1–3 deletion constructs. The
arrow points to the mutants after which ABHD6 failed to reduce the amplitude of the glutamate-induced current. (B) Summary graphs of the peak amplitudes of
10 mM glutamate-induced currents in HEK293T cells transfected with different GluA2/GluA3 deletions, stargazin, and a control vector or vectors encoding ABHD6
(A2D1, control: 24/3, ABHD6: 24/3, p < 0.0001; A2D2, control: 26/3, ABHD6: 26/3, p < 0.0001; A2D3, control: 24/3, ABHD6: 24/3, p < 0.0001; A2D4, control:
24/3, ABHD6: 24/3, p < 0.0001; A2D5, control: 25/3, ABHD6: 24/3, p < 0.001; A2D6, control: 27/3, ABHD6: 27/3, p < 0.001; A2D7, control: 32/4, ABHD6: 32/4,
p < 0.01; A2D8, control: 29/3, ABHD6: 29/3, p < 0.01; A2D9, control: 34/4, ABHD6: 34/4, p < 0.05; A2D10, control: 26/3, ABHD6: 26/3, p > 0.05; A2D11,
control: 27/3, ABHD6: 27/3, p > 0.05; A2D12, control: 26/3, ABHD6: 26/3, p > 0.05; GluA2 full-length, 30/3, ABHD6: 30/3, p < 0.0001; A3D1, control: 24/3,
ABHD6: 24/3, p < 0.0001; A3D2, control: 26/3, ABHD6: 26/3, p < 0.001; A3D3, control: 25/3, ABHD6: 25/3, p < 0.01; A3D4, control: 24/3, ABHD6: 24/3,
p < 0.05; A3D5, control: 26/3, ABHD6: 26/3, p < 0.05; A3D6, control: 25/3, ABHD6: 25/3, p < 0.05; A3D7, control: 27/3, ABHD6: 27/3, p > 0.05; A3D8, control:
26/3, ABHD6: 26/3, p > 0.05; GluA3 full-length, 27/3, ABHD6: 27/3, p < 0.01). Each graph of the peak amplitude in HEK293T cells transfected with various
ABHD6-expressing vectors was normalized to the peak amplitude in HEK293T cells transfected with the control vector. All summary graphs show means ± SEMs;
statistical comparisons by Student’s t-test yielded: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
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FIGURE 4 | The N-terminus of GluAs were not required for ABHD6-induced inhibition. (A) The amino acid sequences of GluA1–3 N-terminal deletion
constructs. (B) Representative traces (left) and summary graphs of the peak amplitudes (right) of 10 mM glutamate-induced currents in HEK293T cells transfected
with GluA1–3 N-terminal deletions, stargazin, and a control vector or vectors encoding ABHD6 (GluA11ATD, control: 24/3, ABHD6: 24/3, p < 0.001; GluA1
full-length, control: 27/3; ABHD6: 27/3; peak: p < 0.001; GluA21ATD, control: 26/3, ABHD6: 26/3, p < 0.0001; GluA2 full-length, control: 30/3; ABHD6: 30/3; peak:
p < 0.0001; GluA31ATD, control: 24/3, ABHD6: 24/3, p < 0.01; GluA3 full-length, control: 27/3; ABHD6: 27/3; peak: p < 0.01). Each graph of the peak amplitude in
HEK293T cells transfected with various ABHD6-expressing vectors was normalized to the peak amplitude in HEK293T cells transfected with the control vector. All
summary graphs show means ± SEMs; statistical comparisons by Student’s t-test yielded: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
CaCl2, 2 mM MgCl2, 0.1 mM EDTA, 1% Triton, and protease
inhibitors), boiled in SDS sample buffer, and subjected to sodium
dodecyl sulfate polyacrylamide gel (SDS-PAGE) electrophoresis.
Western Blotting
SDS-PAGE was performed using NuPAGE precast gels (10%
Bis-Tris gels, Life Technology), then transferred to nitrocellulose
(HATF00010, Millipore), and visualized on immunoblots. The
bounded secondary antibody (IRDye R© 680LT Goat anti-Mouse
IgG and 800CW Goat anti-Rabbit IgG, Odyssey) was detected
by an infrared imaging system (Odyssey). Monoclonal antibodies
against HA-tag (M20003; Abmart) and polyclonal antibodies
against GluA1 (ab1504; Millipore) were used in this study.
RESULTS
Overexpression of ABHD6 Decreased
GluA2- or GluA3-Mediated Currents in
Transfected HEK293T Cells
Previously, we demonstrated that the overexpression of
ABHD6 suppressed the glutamate-induced current in
HEK293T cells expressing GluA1, GluA1 + stargazin, and
GluA1 + GluA2 + stargazin (Wei et al., 2016). Since GluA1–3
are the major AMPAR subunits expressed in the brain (Angulo
et al., 1997; Lee et al., 1998; Lu et al., 2009), we focused our
analysis on GluA2 and GluA3, either alone or in combination.
The overexpression of ABHD6 significantly reduced the peak
amplitude and steady-state amplitude of glutamate-induced
currents in HEK293T cells expressing GluA2 (Figure 1A),
GluA3 (Figure 1B), or GluA2 + GluA3 (Figure 1C), when co-
transfected with stargazin. In the absence of stargazin, ABHD6
overexpression also reduced the amplitude of the currents when
any two among GluA1–3 were coexpressed in the HEK293T
cells (Figures 2A–C). However, similar to GluA1, glutamate
elicited almost undetectable ligand-gated currents in HEK293T
cells expressing either GluA2 or GluA3 alone (Figures 2D,E).
We want to address if the existence of endogenous ABHD6
affect the conclusion in Figures 2D–E, we used immunostaining
and western blotting methods to test the ABHD6 expression
level in HEK293T cells (Supplementary Figure S2). We found
that endogenous ABHD6 can hardly be detected compared
with ABHD6-transfected cells, which means that the effect of
endogenous ABHD6 in HEK293T cells might be neglected.
Furthermore, in the absence of GluAs, the expression of stargazin
alone in HEK293T cells exhibited zero current in response to
the glutamate puffing (Figure 2F), demonstrating the absence
of endogenously expressed GluAs in native HEK293T cells.
These results showed that the overexpression of ABHD6 inhibits
glutamate-induced currents mediated by either heterophilic or
hemophilic AMPARs in transfected HEK293T cells.
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FIGURE 5 | Overexpression of ABHD6 suppressed the surface expression of GluA1–3 in the transfected HEK293T cells. The white lines represent the
scale bar (scale bar = 10 µm). (A) Measurement of the surface (top) and total (bottom) expression of GluA1 in HEK293T cells expressing ABHD6 or a control
(Continued)
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FIGURE 5 | Continued
plasmid together with GluA1 and stargazin. The transfected HEK293T cells were stained with or without permeabilization using an anti-GluA1 antibody. The panels
show representative images (left) and quantification of the puncta intensity (right) (control: n = 182/3; ABHD6: n = 191/3; surface GluA1: p< 0.0001; control: n = 233/3;
ABHD6: n = 218/3; total GluA1: p > 0.05). (B) Measurement of the surface (top) and total (bottom) expression of GluA1 C-terminal deletion A1D14 in HEK293T cells
expressing ABHD6 or a control plasmid together with A1D14 and stargazin. The transfected HEK293T cells were stained with or without permeabilization using an
anti-GluA1 antibody. The panels show representative images (left) and quantification of the puncta intensity (right) (control: n = 248/3; ABHD6: n = 208/3; surface
GluA1: p > 0.05; control: n = 152/3; ABHD6: n = 154/3; total GluA1: p > 0.05). (C) Measurement of the surface (top) and total (bottom) expression of HA-tagged
GluA2 in HEK293T cells expressing ABHD6 or a control plasmid together with GluA2 and stargazin. The transfected HEK293T cells were stained with or without
permeabilization using an anti-HA antibody. The panels show representative images (left) and quantification of the puncta intensity (right) (control: n = 169/3; ABHD6:
n = 187/3; surface GluA2: p < 0.0001; control: n = 147/3; ABHD6: n = 141/3; total GluA2: p < 0.0001). (D) Measurement of the surface (top) and total (bottom)
expression of HA-tagged GluA2 C-terminal deletion A2D10 in HEK293T cells expressing ABHD6 or a control plasmid together with A2D10 and stargazin. The
transfected HEK293T cells were stained with or without permeabilization using an anti-HA antibody. The panels show representative images (left) and quantification
of the puncta intensity (right) (control: n = 97/3; ABHD6: n = 103/3; surface GluA2: p > 0.05; control: n = 115/3; ABHD6: n = 111/3; total GluA2: p > 0.05).
(E) Measurement of the surface (top) and total (bottom) expression of HA-tagged GluA3 in HEK293T cells expressing ABHD6 or a control plasmid together with
GluA3 and stargazin. The transfected HEK293T cells were stained without or with permeabilization using an anti-HA antibody. The panels show representative images
(left) and quantification of the puncta intensity (right) (control: n = 139/3; ABHD6: n = 123/3; surface GluA3: p < 0.0001; control: n = 144/3; ABHD6: n = 111/3; total
GluA3: p > 0.05). (F) Measurement of the surface (top) and total (bottom) expression of HA-tagged GluA3 C-terminal deletion A3D7 in HEK293T cells expressing
ABHD6 or a control plasmid together with A3D7 and stargazin. The transfected HEK293T cells were stained with or without permeabilization using an anti-HA antibody.
The panels show representative images (left) and quantification of the puncta intensity (right) (control: n = 151/3; ABHD6: n = 164/3; surface GluA3: p > 0.05; control:
n = 101/3; ABHD6: n = 103/3; total GluA3: p > 0.05). All summary graphs show means ± SEMs; statistical comparisons by Student’s t-test yielded: ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001.
The C-Terminus of GluAs Mediated the
Inhibitory Effect of ABHD6
The C-terminus of GluA1 has been shown to be crucial for
ABHD6’s inhibitory effect in heterologous cells. ABHD6 failed
to reduce the glutamate-induced current in HEK293T cells
expressing a GluA1 mutant in which the C-tail was deleted
after “SKRMK” (Wei et al., 2016). We then investigated the
importance of similar C-terminal regions in GluA2 and GluA3
for ABHD6-induced inhibition. To this end, we cloned 12 GluA2
C-terminal deletion constructs and eight GluA3 C-terminal
deletion constructs based on the sequence similarity among
GluA1, GluA2, and GluA3 (Figure 3A). Using full-length GluA2
or GluA3 as a positive control, ABHD6 failed to reduce the
amplitude of the glutamate-induced current in HEK293T cells
expressing GluA2 mutants (A2D10, A2D11, A2D12) and GluA3
mutants (A3D7 and A3D8)(Figure 3B and Supplementary
Figure S1). Interestingly, these results point out that the longest
ABHD6-resistant GluA mutants, A2D10 (ending with AKRMKV
in GluA2) and A3D7 (ending with SKRMKL in GluA3), and the
previously identified A1D14 (ending with SKRMK in GluA1),
share sequence similarity to some extent (Figure 3A). Thus,
like GluA1, the C-terminal regions of GluA2 and GluA3 are
required for ABHD6’s inhibition of AMPAR-mediated currents
in transfected HEK293T cells.
In addition, we generated N-terminal partial deletion mutants
for GluA1, GluA2, and GluA3, and tested these mutants in
transfected HEK293T cells. Because the extracellular ligand-
binding domain is essential for the receptors to respond to
glutamate, we removed the entire amino-terminal domain
(ATD) from GluA1–3 (Figure 4A). The results showed that in
cells expressing GluA11ATD, GluA21ATD, and GluA31ATD,
ABHD6 suppressed the glutamate-induced currents to a similar
extent as those of full-length GluA1–3 (Figure 4B). These results
demonstrated that the ATDs of GluAs are not required for
ABHD6’s inhibition of AMPAR-mediated currents.
Overexpression of ABHD6 Suppressed
the Surface Expression of GluA1–3 in the
Transfected HEK293T Cells
To investigate whether the observed reduction in AMPAR-
mediated currents in the heterogonous cells is due to a specific
loss of surface-localized AMPARs, or an overall reduction in the
expression level of total GluAs, we performed quantitative
immunostaining of GluA1–3 from both permeabilized
and non-permeabilized HEK293T cells expressing various
GluAs together with stargazin. Our results revealed that the
coexpression of ABHD6 reduced the surface expression of
GluA1 (Figure 5A), GluA2 (Figure 5C), or GluA3 (Figure 5E)
compared with the control groups. However, the total GluA1
immunostaining signal from permeabilized HEK293T cells
showed no difference between HEK293T cells expressing
ABHD6 and stargazin together with GluA1 (Figure 5A) or
GluA3 (Figure 5E), compared to control groups. Furthermore,
overexpression ABHD6 increased the total expression of full-
length GluA2 (Figure 5C). Thus, ABHD6 specifically affected
the surface expression of GluA subunits when coexpressed with
stargazin.
Because ABHD6 failed to reduce the ligand-induced currents
when expressing C-terminal deletion mutants of GluAs (Figure 3;
GluA2-A2D10, and GluA3-A3D7, and GluA1-A1D14), we
next explored whether these mutations are also resistant
to the effects of ABHD6 on the surface expression of
AMPARs. By quantifying the immunostaining signal from non-
permeabilized and permeabilized HEK293T cells expressing
A1D14 (Figure 5B), A2D10 (Figure 5D), and A3D7 (Figure 5F),
we found that the ABHD6-induced suppression of surface GluAs
was abolished, and the total expression levels of GluAs remained
unchanged compared to control groups. These results suggested
that the same GluAs C-terminal mutants abolished the inhibitory
effect of ABHD6 on glutamate-induced currents and the surface
expression of AMPARs.
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FIGURE 6 | ABHD6 directly bound to GluA1–3 though the C-terminus of the receptors. Pull-down of GluA1–3 or various deletions in HEK 293T cells. ABHD6
was immobilized by an myc-tag antibody, and binding was visualized by detection for the GluA1 or HA-tag. (A) Pull-down of GluA1 (left) or HA-tagged A1D14 (right)
expressed in transfected HEK293T cells together with myc-tagged ABHD6 by an anti-myc antibody. (B) Pull-down of HA-tagged GluA2 (left) or A2D10 (right)
expressed in transfected HEK293T cells together with myc-tagged ABHD6 by an anti-myc antibody. (C) Pull-down of HA-tagged GluA3 (left) or A3D7 (right)
expressed in transfected HEK293T cells together with myc-tagged ABHD6 by an anti-myc antibody.
ABHD6 Directly Bound to GluA1–3
Though the C-Terminus of the Receptors
The notion of ABHD6–AMPAR association was first proposed by
a high-resolution proteomics study (Schwenk et al., 2012), and
later confirmed by our biochemistry study showing that ABHD6
coimmunoprecipitated GluA1 in transfected heterologous cells
(Wei et al., 2016). In the present study, we used a similar approach
to test whether ABHD6 coimmunoprecipitated GluA2 and
GluA3 when transfected in the HEK293T cells. We found that
ABHD6 was specifically coimmunoprecipitated with full-length
GluA2 (Figure 6B) or GluA3 (Figure 6C) only when ABHD6 and
GluA1 were coexpressed. Next, to test whether the interactions
between ABHD6 and GluA2/3 also require the C-tail of the GluA
subunits, we used ABHD6 as a bait to coimmunoprecipitate
GluA2 and GluA3 C-terminal mutations that abolished ABHD6’s
inhibitory effect on the ligand-induced currents and surface
expression of GluAs in transfected HEK293T cells. We found that
the C-terminal deletion mutations, GluA1-A1D14 (Figure 6A),
GluA2-A2D10 (Figure 6B), and GluA3-A3D7 (Figure 6C)
all failed to coimmunoprecipitate with ABHD6 in the pull-
down assay. These results clearly suggested that ABHD6
binds to all three GluA subunits through their C-terminus
domains, and implied that this binding might serve as the
underlying mechanism for the functional effects observed in
Figures 1–3.
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DISCUSSION
ABHD6, a monoacylglycerol lipase, was previously found to
inhibit the glutamate-induced currents of GluA1-containing
AMPARs in both heterologous cells and neurons (Wei et al.,
2016). In this study, we extended our observations to GluA2-
and GluA3-containing AMPARs. Our results show that the
overexpression of ABHD6 significantly reduced the peak
amplitude and steady-state amplitude of glutamate-induced
currents in HEK293T cells expressing GluA2, GluA3, or
GluA2 + GluA3 when co-transfected with stargazin (Figure 1).
In the absence of stargazin, ABHD6 overexpression also reduced
the amplitude of currents when any two among GluA1–
3 were coexpressed in the HEK293T cells (Figure 2). Our
results also revealed that the suppression effect of ABHD6
on the surface AMPAR levels is independent of the subunit
composition of the AMPARs in transfected HEK293T cells
(Figure 5).
Similar to previous findings in GluA1, the C-terminal domains
of GluA2 and GluA3 are required for ABHD6 to inhibit the
ligand-gated current in transfected HEK293T cells (Figure 3),
and to bind with AMPARs in the co-immunoprecipitation (co-
IP) experiments. ABHD6 can significantly decrease GluA1–3
surface expression, but without the C-terminus, the GluA1–
3 surface expression level was restored (Figure 5). Combining
this with the co-IP experiments, we can infer that ABHD6
directly binds to GluA1–3 C-terminal regions, and selectively
inhibits the surface delivery of AMPARs. These observations
also suggest that ABHD6 functions during receptor trafficking.
According to our results, ABHD6 can interact with the
GluA1–3 C-terminus, but the specific interaction region
or motif still needs further investigation. The binding of
ABHD6 with the GluA1–3 C-terminus is consistent with the
observation that ABHD6 is a membrane-bound protein, but is
different from stargazin, which interacts with the glutamate-
binding domain of AMPARs (Tomita et al., 2007). Stargazin
increased the ligand-induced current in oocytes expressing full-
length GluA1 or in GluA1 lacking the ATD. However, the
introduction of a Lurcher mutation (A636T) in the glutamate-
binding domain of GluA1, or a L497Y mutation in the
extracellular S1 domain, abolished the stargazin’s enhancement
of glutamate-induced currents (Tomita et al., 2007). Thus,
ABHD6 and stargazin interact with different domains of
AMPARs.
Furthermore, our data clearly demonstrated that ABHD6’s
inhibition on AMPAR trafficking is not dependent on the
existence of stargazin. This is in contrast to CNIH-2/3 or PORCN,
two other auxiliary proteins recently found in the macro-
complex of AMPARs (Mauric et al., 2013). The overexpression
of CNIH-2/3 facilitated the membrane delivery of AMPARs
and increased the amplitude of glutamate-elicited currents in
heterologous cells and neurons (Schwenk et al., 2009; Kato
et al., 2010; Shi et al., 2010; Coombs et al., 2012; Gill et al.,
2012; Harmel et al., 2012). CNIH-2/3 colocalized with γ-8 but
not found in the AMPAR complex lack stargazin (γ-2) and γ-
3 (Schwenk et al., 2009; Kato et al., 2010; Gill et al., 2011).
The membrane localization of CNIH-2 is critically dependent
on γ-8, reflected as the absence of surface CNIH-2 in the
cerebellum where γ-8 was also absent (Gill et al., 2011).
This effect is subject to TARP modulation, since coexpression
of CNIH-2 with GluAs and γ-2 showed a more profound
increase in current intensity in heterologous cells than that
in γ-8 (Gill et al., 2012). PORCN is another auxiliary protein
found in the AMPAR macro-complex (Schwenk et al., 2012).
Similar to ABHD6, PORCN negative regulates the trafficking of
AMPARs in both transfected heterologous cells and knockout
(KO) neurons. However, the effect of PORCN seems to be
mediated with a TAPR-dependent mechanism. Knockdown
PORCN dissociates γ-8 from the AMPAR complex and alters the
subunit composition of AMPARs in the hippocampal neurons
(Erlenhardt et al., 2016). Thus, ABHD6 and stargazin function
in a divergent manner in trafficking the AMPARs to the plasma
membrane.
CONCLUSION
We extend our previous observation on the functional interaction
of ABHD6 and GluA1-containing receptors to GluA2- and
GluA3-containing receptors. These results revealed a negative
mechanism governing the membrane trafficking of AMPARs
through ABHD6 that is independent on stargazin. The limitation
of these studies is the lack of in vivo studies of this interaction
using KO animals, which requires further investigation.
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FIGURE S1 | The C-terminus of GluAs mediated the inhibitory effect of
ABHD6. (A) Summary graphs of the peak amplitudes of 10 mM
glutamate-induced currents in HEK293T cells transfected with GluA2 deletion
A2D10, A2D11, A2D12, and GluA2 full-length. (B) Summary graphs of the peak
amplitudes of 10 mM glutamate-induced currents in HEK293T cells transfected
with GluA3 deletion A3D7, A3D8, and GluA3 full-length. (A2D10, control: 26/3,
ABHD6: 26/3, p > 0.05; A2D11, control: 27/3, ABHD6: 27/3, p > 0.05; A2D12,
control: 26/3, ABHD6: 26/3, p > 0.05; GluA2 full-length, 30/3, ABHD6: 30/3,
p < 0.0001; A3D7, control: 27/3, ABHD6: 27/3, p > 0.05; A3D8, control: 26/3,
ABHD6: 26/3, p > 0.05; GluA3 full-length, 27/3, ABHD6: 27/3, p < 0.01).
FIGURE S2 | The expression level of endogenous ABHD6 in HEK293T cells
is very low compared with HEK293T cells transfected with ABHD6. The
white lines represent the scale bar (scale bar 10µm). (A) Measurement
of the expression level of ABHD6 in HEK293T cells expressing ABHD6
(bottom) or a control plasmid (top). The transfected or untransfected HEK293T
cells were stained with permeabilization using an anti-ABHD6 antibody. The
panels show representative images. (B) Measurement of the expression level of
ABHD6 in HEK293T cells expressing ABHD6 (right) or a control plasmid (left)
using Western blotting. ABHD6 was detected using an anti-ABHD6
antibody.
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